-
Ibrunib (Ibrutinib) 140mg online
Ibrutinib 140mg‘s brand name is IMBRUVICA® from rx786.com . Ibrunib is a generic kinase inhibitor from Julphar Bangladesh, Julphar is the largest generic pharmaceutical manufacturer in MENA. Julphar Bangladesh Ltd., a subsidiary of Julphar.
$1,087.00Ibrunib (Ibrutinib) 140mg online
$1,087.00 -
Ibrutix (IMBRUVICA) Ibrutinib online
Mantle cell lymphoma (MCL) who have received at least one prior therapy. Accelerated approval was granted for this indication based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
1,269.00 per 120 Tablets
$1,269.00Ibrutix (IMBRUVICA) Ibrutinib online
$1,269.00 -
-
Luciolap(lynparza)Olaparib 50mg online
in patients with deleterious or suspected deleterious gBRCAm, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting. Patients with hormone receptor (HR)-positive breast cancer should have been treated with a prior endocrine therapy or be considered inappropriate for endocrine therapy. Select patients for therapy based on an FDA-approved companion diagnostic for Luciolap.
1,399.00 per 112 Tablets
$1,399.00Luciolap(lynparza)Olaparib 50mg online
$1,399.00 -
Lucibru 140 (Ibrutinib) 140mg online
Mantle cell lymphoma (MCL) who have received at least one prior therapy. Accelerated approval was granted for this indication based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
1,399.00 per 120 Capsules
$1,399.00Lucibru 140 (Ibrutinib) 140mg online
$1,399.00 -
Lucilenva (LENVIMA) lenvatinib 10mg online
For more Prescribing information,please check the → “FDA Prescribing Information”.
1,399.00 per 30 Capsules
$1,399.00